Siemens Healthineers AG (OTCMKTS:SMMNY) Short Interest Down 59.9% in July

Siemens Healthineers AG (OTCMKTS:SMMNY) was the recipient of a significant decline in short interest in the month of July. As of July 31st, there was short interest totaling 50,368 shares, a decline of 59.9% from the July 15th total of 125,563 shares. Based on an average daily volume of 196,684 shares, the days-to-cover ratio is currently 0.3 days.

Siemens Healthineers Price Performance

Shares of Siemens Healthineers stock opened at $22.72 on Monday. The business’s 50 day simple moving average is $20.48 and its 200 day simple moving average is $21.51. Siemens Healthineers has a 52-week low of $19.20 and a 52-week high of $28.92.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Siemens Healthineers from a “strong sell” rating to a “hold” rating in a research note on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.

About Siemens Healthineers

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.